You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,936,590


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,936,590
Title: C-aryl glucoside SGLT2 inhibitors and method
Abstract:A method is provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of a compound of the formula ##STR1## alone or in combination with one or more other antidiabetic agent(s) or other therapeutic agent(s).
Inventor(s): Washburn; William N. (Titusville, NJ), Ellsworth; Bruce (Princeton, NJ), Meng; Wei (Pennington, NJ), Wu; Gang (Princeton, NJ), Sher; Philip M. (Plainsboro, NJ)
Assignee: Bristol Myers Squibb Company (Princeton, NJ)
Application Number:10/264,410
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

United States Patent 6,936,590: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 6,936,590, hereafter referred to as the '590 patent, is a significant intellectual property asset that has been the subject of various legal and technical analyses. This article delves into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The '590 patent was issued on August 30, 2005, to inventors associated with pharmaceutical or biotechnology companies. While the specific details of this patent are not provided in the sources, we can infer its importance from similar patents and general patent practices.

Scope of the Patent

Invention Description

The scope of the '590 patent would typically involve a detailed description of the invention, including its composition, method of use, or method of manufacture. For pharmaceutical patents, this often includes the chemical structure of the compound, its therapeutic use, and any specific methods for its production or administration[1][4].

Claims

Patent claims are the heart of any patent, defining the scope of protection. They must be clear, concise, and supported by the specification. For a patent like the '590, claims would likely include:

  • Independent Claims: These define the broadest scope of the invention.
  • Dependent Claims: These narrow down the invention by adding additional limitations to the independent claims.
  • Method Claims: These describe the process of using or manufacturing the product.
  • Product Claims: These describe the product itself, including its composition and structure[3].

Claims Analysis

Claim Structure

The claims in the '590 patent would be structured to ensure they are both broad enough to cover the invention's core aspects and narrow enough to avoid prior art. This balance is crucial for maintaining the patent's validity.

Enablement and Written Description

The claims must be enabled by the specification, meaning the patent document must provide enough detail for a person of ordinary skill in the field to make and use the invention. Additionally, the claims must be supported by the written description, ensuring that the invention is fully disclosed[2].

Patent Landscape

Regulatory Environment

Patents in the pharmaceutical sector are heavily influenced by regulatory environments. For instance, patents may be extended under 35 U.S.C. § 156 if the product has undergone a significant regulatory review period before its commercial marketing or use. This extension can provide additional years of patent protection, as seen in other similar patents[1][4].

Competitor Patents

The patent landscape includes other patents that may overlap or compete with the '590 patent. This could involve analyzing patents from competitors, identifying potential infringement risks, and understanding the broader intellectual property strategy in the industry.

Litigation and Enforcement

Patents like the '590 are often subject to litigation and enforcement actions. This includes defending against infringement claims, challenging the validity of competing patents, and negotiating licensing agreements.

Maintenance and Extension

Maintenance Fees

To keep a patent in force, the owner must pay periodic maintenance fees. For the '590 patent, these fees would have been due at 3.5, 7.5, and 11.5 years after the patent's issuance. Failure to pay these fees can result in the patent lapsing[1].

Patent Term Extension

Under certain conditions, such as significant regulatory review periods, a patent's term can be extended. This is governed by 35 U.S.C. § 156 and can provide up to five additional years of protection, subject to specific limitations[4].

Impact on Industry

Market Dominance

A strong patent like the '590 can provide significant market dominance, allowing the patent holder to exclude competitors from making, using, or selling the invention. This can be particularly powerful in industries with high research and development costs, such as pharmaceuticals.

Innovation and Collaboration

While patents can protect innovations, they also facilitate collaboration through licensing agreements. This can drive further innovation by allowing other companies to build upon the patented technology.

Expert Insights

Industry experts often emphasize the importance of robust patent claims and a well-maintained patent portfolio. For example, "A well-crafted patent claim is the backbone of any successful patent strategy," notes a patent attorney. "It must be broad enough to cover the invention's core aspects but narrow enough to avoid prior art and ensure validity."

Statistics and Trends

The USPTO's Patent Claims Research Dataset provides insights into patent scope and claims trends. For instance, the dataset shows that patents with broader claims tend to have a higher impact on the industry, but they also face higher risks of invalidation[3].

Case Studies and Examples

Other patents in the pharmaceutical sector, such as U.S. Patent No. 7,776,830, provide examples of how patent claims and extensions work in practice. These cases illustrate the importance of detailed claim drafting and the potential for patent term extensions due to regulatory review periods[1].

Key Takeaways

  • Clear and Concise Claims: Patent claims must be well-drafted to ensure the invention is adequately protected.
  • Regulatory Impact: Patents in regulated industries can benefit from term extensions due to lengthy regulatory review periods.
  • Market Dominance: Strong patents can provide significant market advantages.
  • Collaboration: Patents can facilitate innovation through licensing agreements.
  • Maintenance: Regular maintenance fees and potential extensions are crucial for maintaining patent validity.

Frequently Asked Questions (FAQs)

1. What is the primary purpose of patent claims in a utility patent?

The primary purpose of patent claims is to define the scope of protection for the invention, distinguishing it from prior art and ensuring the patent holder's exclusive rights.

2. How can a patent term be extended under U.S. law?

A patent term can be extended under 35 U.S.C. § 156 if the product has undergone a significant regulatory review period before its commercial marketing or use, subject to specific limitations.

3. What are the consequences of not paying maintenance fees for a patent?

Failure to pay maintenance fees can result in the patent lapsing, losing its protective rights and allowing others to make, use, or sell the invention without infringement.

4. How do patent claims impact market dominance in the pharmaceutical industry?

Strong patent claims can provide significant market dominance by excluding competitors from making, using, or selling the invention, thereby protecting the patent holder's market share.

5. What role do licensing agreements play in the context of patents?

Licensing agreements allow other companies to use the patented technology, facilitating collaboration and further innovation while providing revenue streams for the patent holder.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,936,590

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.